# Spatial transcriptomics and artificial intelligence: a scoping review of emerging applications in head and neck pathology

**Authors:** Najwa Yousef, Wenshan Wu, Shahd Alajaji, Akshya Mahadevan, Ahmed S. Sultan, Erin K. Molloy, Joe T. Nguyen

PMC · DOI: 10.1007/s12105-025-01876-x · 2026-03-04

## TL;DR

This review explores how spatial transcriptomics and AI can improve understanding and treatment of head and neck diseases by analyzing gene expression in tissue.

## Contribution

The paper identifies a gap in using spatial transcriptomics and AI for head and neck pathology and suggests future research directions.

## Key findings

- Only ten relevant studies were found on AI and spatial transcriptomics in head and neck pathology.
- Integrating spatial, histological, and molecular data can improve diagnosis and treatment strategies.
- Multimodal AI frameworks are needed to advance clinical decision-making in head and neck disease management.

## Abstract

Single cell spatially resolved transcriptomics (ST) has revolutionized molecular profiling by providing the visualization of gene expression within its native tissue architecture, enabling insights into cellular heterogeneity, tumor microenvironment (TME) composition, and the molecular pathways driving disease progression. At the same time, advances in artificial intelligence (AI)-driven workflows have demonstrated significant applications within the medical field and are expected to transform the way complex diagnostic and prognostic challenges are approached. In addition, integrative analyses of spatial, histological and molecular data, offer new opportunities to uncover driver genes, identify new immunohistochemical biomarkers, and inform personalized treatment strategies, ultimately contributing to enhanced clinical decision-making and improved patient outcomes.

This scoping review aims to examine recent research leveraging AI in ST to study head and neck (H&N) pathology and highlight future applications of these technologies for improving the diagnosis, risk stratification, and malignant transformation prediction.

Scoping literature review was conducted in accordance with PRISMA guidelines using seven electronic databases, including PubMed, Embase, Cochrane Library, IEEE Xplore, EBSCOhost, Springer, and Google Scholar. Database-specific search strategies and manual reference screening were applied to identify relevant studies published between January 2014 and May 2025.

Ten relevant studies were included in this review after removal of duplicates and exclusion of irrelevant articles due to incompatible formats, lack of spatial transcriptomics data, not including head and neck human tissue, or unavailable full-text access.

This review identifies a substantial gap in the application of ST and AI within H&N pathology. Future research should focus on developing multimodal, AI-driven frameworks that integrate histopathology, spatial gene expression, and clinical metadata to improve early detection, risk stratification, and clinical decision-making in the management of OPMDs. Broader adoption of these approaches is essential to advance translational research and improve patient outcomes.

## Full-text entities

- **Genes:** DNMT1 (DNA methyltransferase 1) [NCBI Gene 1786] {aka ADCADN, AIM, CXXC9, DNMT, HSN1E, MCMT}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, CD274 (CD274 molecule) [NCBI Gene 29126] {aka ADMIO5, B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1}, VTCN1 (V-set domain containing T cell activation inhibitor 1) [NCBI Gene 79679] {aka B7-H4, B7H4, B7S1, B7X, B7h.5, PRO1291}, GRN (granulin precursor) [NCBI Gene 2896] {aka CLN11, FTD2, GEP, GP88, PCDGF, PEPI}, EZH2 (enhancer of zeste 2 polycomb repressive complex 2 subunit) [NCBI Gene 2146] {aka ENX-1, ENX1, EZH2b, KMT6, KMT6A, WVS}, IGF1 (insulin like growth factor 1) [NCBI Gene 3479] {aka IGF, IGF-I, IGFI, MGF}, PDCD1 (programmed cell death 1) [NCBI Gene 5133] {aka ADMIO4, AIMTBS, CD279, PD-1, PD1, SLEB2}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, COL5A1 (collagen type V alpha 1 chain) [NCBI Gene 1289] {aka EDSC, EDSCL1, FMDMF}, F3 (coagulation factor III, tissue factor) [NCBI Gene 2152] {aka CD142, TF, TFA}, FN1 (fibronectin 1) [NCBI Gene 2335] {aka CIG, ED-B, FINC, FN, FNZ, GFND}, PEMT (phosphatidylethanolamine N-methyltransferase) [NCBI Gene 10400] {aka PEAMT, PEMPT, PEMT2, PLMT}
- **Diseases:** ISCs (MESH:D000092423), OSCC (MESH:D000077195), H&amp;N SCC (MESH:D002294), chronic (MESH:D002908), non (MESH:C580335), infectious (MESH:D003141), ST (MESH:D008569), invasive (MESH:D009361), OSF (MESH:D009914), dysregulation (MESH:D021081), H&amp;N (MESH:D000848), OPMD (MESH:D039141), H&amp;N SCC) cancer (MESH:D018307), OPMDs (MESH:C537245), Proliferative leukoplakia (MESH:D007971), WSI (MESH:C564543), DL (MESH:D007859), tumorigenesis (MESH:D063646), oral cancer (MESH:D009062), lymph node metastasis (MESH:D008207), oral epithelial dysplasia (MESH:C567703), oral lichenoid lesions (MESH:D009059), breast cancer (MESH:D001943), Head and Neck (MESH:D006258), central nervous system tumors (MESH:D016543), B (MESH:D006509), squamous intraepithelial neoplasia (MESH:D002578), Oral lichen planus (MESH:D017676), Cancer (MESH:D009369), verrucous carcinoma (MESH:D018289), in-situ (MESH:D002278), C (OMIM:211750), oral mucosal abnormalities (MESH:D009056), Oral leukoplakia (MESH:D007972), precancerous (MESH:D011230), lichenoid (MESH:D017512), dysplasia (MESH:D015792), inflammation (MESH:D007249), metastasis (MESH:D009362)
- **Chemicals:** Formalin (MESH:D005557), nivolumab (MESH:D000077594), polyamine (MESH:D011073), ST (-), paraffin (MESH:D010232), H&amp;E (MESH:D006371)
- **Species:** Human papillomavirus (species) [taxon 10566], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12961049/full.md

---
Source: https://tomesphere.com/paper/PMC12961049